Related Experiment Video
Updated: Nov 2, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma
Yujie Zhang1, Yanyan Wang2, Liwei Ying1
1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
Osteosarcoma is the most common primary bone malignancy, typically occurring in childhood or adolescence. Unfortunately, the clinical outcomes of patients with osteosarcoma are usually poor because of the aggressive nature of this disease and few treatment advances in the past four decades. N6-methyladenosine (m6A) is one of the most extensive forms of RNA modification in eukaryotes found both in coding and non-coding RNAs. Accumulating evidence suggests that m6A-related factors are dysregulated in multiple osteosarcoma processes. In this review, we highlight m6A modification implicated in osteosarcoma, describing its pathophysiological role and molecular mechanism, as well as future research trends and potential clinical application in osteosarcoma.
Insights
N6-methyladenosine (m6A) modification is frequently altered in osteosarcoma, impacting disease progression. Understanding m6A
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Osteosarcoma is a prevalent bone cancer with poor patient outcomes due to its aggressive nature and limited treatment progress.
- N6-methyladenosine (m6A) is a widespread RNA modification in eukaryotes, affecting both coding and non-coding RNAs.
- Dysregulation of m6A-related factors is increasingly observed in various osteosarcoma processes.
Purpose of the Study:
- To review the role of m6A modification in osteosarcoma.
- To elucidate the pathophysiological functions and molecular mechanisms of m6A in osteosarcoma.
- To explore future research directions and potential clinical applications of m6A in osteosarcoma treatment.
Main Methods:
- Literature review of studies investigating m6A modification in osteosarcoma.
- Analysis of existing data on m6A regulators and their impact on osteosarcoma.
- Synthesis of information on the pathophysiological roles and molecular mechanisms of m6A.
Main Results:
- m6A modification plays a significant role in osteosarcoma development and progression.
- Specific m6A-related factors are dysregulated, influencing key cellular processes in osteosarcoma.
- Evidence suggests m6A could be a potential therapeutic target.
Conclusions:
- m6A modification is a critical factor in osteosarcoma.
- Further research into m6A mechanisms may reveal novel therapeutic strategies for osteosarcoma.
- Targeting m6A pathways holds promise for improving osteosarcoma patient outcomes.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Regulation of Expression at Multiple Steps
RNA Stability
MicroRNAs
MicroRNAs

